PHS
BPMC
PFM Health Sciences’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.21M | Buy |
48,444
+1,991
| +4% | +$255K | 0.53% | 38 |
|
2025
Q1 | $4.11M | Buy |
46,453
+3,613
| +8% | +$320K | 0.3% | 43 |
|
2024
Q4 | $3.74M | Buy |
+42,840
| New | +$3.74M | 0.23% | 51 |
|
2023
Q1 | – | Sell |
-130,366
| Closed | -$5.71M | – | 79 |
|
2022
Q4 | $5.71M | Hold |
130,366
| – | – | 0.2% | 62 |
|
2022
Q3 | $8.59M | Buy |
+130,366
| New | +$8.59M | 0.31% | 62 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 63 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 58 |
|
2019
Q2 | – | Sell |
-964,075
| Closed | -$77.2M | – | 84 |
|
2019
Q1 | $77.2M | Sell |
964,075
-506,361
| -34% | -$40.5M | 1.71% | 18 |
|
2018
Q4 | $79.3M | Buy |
1,470,436
+30,398
| +2% | +$1.64M | 2.11% | 13 |
|
2018
Q3 | $112M | Buy |
1,440,038
+595,957
| +71% | +$46.5M | 1.65% | 11 |
|
2018
Q2 | $53.6M | Sell |
844,081
-73,909
| -8% | -$4.69M | 0.84% | 39 |
|
2018
Q1 | $84.2M | Buy |
917,990
+51,250
| +6% | +$4.7M | 1.71% | 16 |
|
2017
Q4 | $65.4M | Sell |
866,740
-762,346
| -47% | -$57.5M | 1.55% | 23 |
|
2017
Q3 | $113M | Buy |
1,629,086
+342,636
| +27% | +$23.9M | 2.23% | 5 |
|
2017
Q2 | $65.2M | Buy |
1,286,450
+234,438
| +22% | +$11.9M | 1.76% | 19 |
|
2017
Q1 | $42.1M | Buy |
1,052,012
+252,061
| +32% | +$10.1M | 1.05% | 39 |
|
2016
Q4 | $22.4M | Buy |
799,951
+246,866
| +45% | +$6.92M | 0.63% | 47 |
|
2016
Q3 | $16.4M | Sell |
553,085
-1,093,431
| -66% | -$32.5M | 0.48% | 59 |
|
2016
Q2 | $33.3M | Buy |
1,646,516
+226,005
| +16% | +$4.58M | 1.01% | 37 |
|
2016
Q1 | $25.6M | Buy |
1,420,511
+412,279
| +41% | +$7.44M | 0.79% | 38 |
|
2015
Q4 | $26.6M | Sell |
1,008,232
-19,321
| -2% | -$509K | 0.81% | 41 |
|
2015
Q3 | $21M | Buy |
1,027,553
+165,388
| +19% | +$3.38M | 0.59% | 48 |
|
2015
Q2 | $20.9M | Buy |
+862,165
| New | +$20.9M | 0.53% | 55 |
|